Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial.
Lei Yang, Wenbo Wang, Jing Su et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized phase II trial evaluated a multidisciplinary mHealth rehabilitation program for 111 patients with abdominal cancer undergoing concurrent chemoradiotherapy (CCRT). The intervention group demonstrated significantly higher handgrip strength at the end of CCRT, with an adjusted mean difference of 4.87 kg compared to standard care (P < .001).
Key findings
- The mHealth rehabilitation group had an adjusted mean handgrip strength increase of 4.87 kg compared to standard care (P < .001).
- Significant preservation of body weight was observed in the mHealth group (P = .005).
- Skeletal muscle mass was better preserved in the mHealth group (P < .001).
- Lower rates of hematological toxicity were reported in the mHealth group (P < .05).
Why it matters
This study highlights the potential of mHealth interventions to mitigate muscle loss and improve nutritional status in patients undergoing CCRT, which is crucial for maintaining treatment tolerance and overall health.
What to keep in mind
The study's open-label design, population heterogeneity, and exploratory nature of secondary analyses limit the strength of the conclusions.